X0306 4 2018-05-23 0 0001642380 OncoCyte Corp OCX 0001662454 MECHEM KRISTINE C. 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 0 1 0 0 VP of Marketing Option to Purchase Common Stock 2.35 2018-05-23 4 A 0 125000 0.00 A 2028-05-22 Common Stock 125000 125000 D Option to Purchase Common Stock 4.70 2027-02-16 Common Stock 67500 67500 D Option to Purchase Common Stock 3.06 2026-02-15 Common Stock 60000 60000 D Option to Purchase Common Stock 3.16 2025-08-03 Common Stock 100000 100000 D These options vest as to one-third of the shares on each of the completion of the clinical utility study for OncoCyte's DetermaVu product candidate, the filing of the Medicare dossier for the Medicare local coverage determination, and obtaining a Medicare local coverage determination for OncoCyte's DetermaVu product candidate. One quarter of the options vested on February 16, 2018, and the balance shall vest thereafter in 36 monthly installments upon the completion of each month of continuous employment. One quarter of the options vested on February 15, 2017, and the balance shall vest thereafter in 36 monthly installments upon the completion of each month of continuous employment. One quarter of the options vested on August 3, 2016, and the balance shall vest thereafter in 36 monthly installments upon the completion of each month of continuous employment. /s/Kristine C. Mechem 2018-06-01